Skip to content

Corbus Pharmaceuticals Holdings, Inc.: filings

Every Corbus Pharmaceuticals Holdings, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026401110001193125-26-338274
10-Q2026-05-12fiscal Q1 202638770001193125-26-219707
10-K2026-03-09fiscal FY 202544880001193125-26-098530
10-Q2025-11-12fiscal Q3 2025411150001193125-25-277748
10-Q2025-08-05fiscal Q2 2025411150000950170-25-103118
10-Q2025-05-06fiscal Q1 202541830000950170-25-064507
10-K2025-03-11fiscal FY 202444880000950170-25-037335
10-Q2024-11-07fiscal Q3 2024431190000950170-24-123486
10-Q2024-08-06fiscal Q2 2024431190000950170-24-091922
10-Q2024-05-07fiscal Q1 202442850000950170-24-054625
10-K2024-03-12fiscal FY 202345880000950170-24-030133
10-Q2023-11-07fiscal Q3 2023441180000950170-23-060377
10-Q2023-08-08fiscal Q2 2023441180000950170-23-039960
10-Q2023-05-09fiscal Q1 202344880000950170-23-019825
10-K2023-03-07fiscal FY 202246900000950170-23-006469
10-Q2022-11-08fiscal Q3 2022451260000950170-22-023282
10-Q2022-08-09fiscal Q2 2022431130000950170-22-016150
10-Q2022-05-10fiscal Q1 202243840000950170-22-009050
10-K2022-03-08fiscal FY 202143830000950170-22-003145
10-Q2021-11-12fiscal Q3 2021421110000950170-21-004269
10-Q2021-08-12fiscal Q2 2021421100001493152-21-019441
10-Q2021-05-13fiscal Q1 202139750001493152-21-011221
10-K2021-03-15fiscal FY 202036710001493152-21-006016
10-Q2020-11-09fiscal Q3 202034870001493152-20-020841
10-Q/A2020-08-31fiscal Q2 2020371010001493152-20-017022
10-Q2020-08-06fiscal Q2 2020371010001493152-20-014895
10-Q2020-05-11fiscal Q1 202033670001493152-20-008248
10-K2020-03-16fiscal FY 201933650001493152-20-004077
10-Q2019-11-07fiscal Q3 201933840001493152-19-016601
10-Q2019-08-08fiscal Q2 2019381020001493152-19-011835
10-Q2019-05-09fiscal Q1 201935740001493152-19-006611
10-K2019-03-12fiscal FY 201832640001493152-19-003143
10-Q2018-11-08fiscal Q3 201831790001493152-18-015417
10-Q2018-08-08fiscal Q2 201831790001493152-18-011140
10-Q2018-05-10fiscal Q1 201828570001493152-18-006568
10-K2018-03-12fiscal FY 2017291280001493152-18-003208
10-Q2017-11-08fiscal Q3 201730760001493152-17-012574
10-Q2017-08-09fiscal Q2 201730780001493152-17-008712
10-Q2017-05-09fiscal Q1 201726510001493152-17-004896
10-K2017-03-08fiscal FY 201626520001493152-17-002256
10-Q2016-11-10fiscal Q3 201628760001493152-16-014751
10-Q2016-08-12fiscal Q2 201628760001493152-16-012283
10-Q2016-05-13fiscal Q1 201628560001564590-16-019363
10-K2016-03-28fiscal FY 201528560001564590-16-015403
10-Q2015-11-10fiscal Q3 201526710001564590-15-010364
10-Q2015-08-13fiscal Q2 201526680001193125-15-289161
10-Q2015-05-13fiscal Q1 201525500001193125-15-184856
10-K2015-02-10fiscal FY 201428520001193125-15-040326
10-Q2014-11-13fiscal Q3 201424600001193125-14-410145

Inspect the source

Entity
Corbus Pharmaceuticals Holdings, Inc. / CIK 0001595097
Captured
2026-09-20T09:24:35.285Z
SEC response SHA-256
946cd75b294f9564550986f5a835381ea0b20b9b7c1140d70659a5c384e7d54a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001595097.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))